Longeveron

+$0.17 (+2.75%) As of 12:58 PM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Longeveron and other ETFs, options, and stocks.

About LGVN

Longeveron LLC is a clinical stage biotechnology company that engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors.

CEO
Geoff Green
Employees
12
Headquarters
Miami, Florida
Founded
2014

LGVN Key Statistics

Market Cap
125.43M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
100.14K
High Today
$6.54
Low Today
$6.15
Open Price
$6.28
Volume
118.76K
52 Week High
$12.48
52 Week Low
$5.15

LGVN Earnings

-$0.18
-$0.12
-$0.06
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 13, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure